Published:  Feb 27, 2013DOI: 10.7324/JAPS.2013.30227
The aim of this research is to develop thermo sensitive drug vehicles for glaucoma therapy in in-situ form to overcome the problems of poor bioavailability, naso lachrymal drainage and rapid precorneal elimination exhibited by conventional eye drops. Thermo sensitive ophthalmic drop was prepared using cold method by mixing thermo sensitive polymer pluronic F-127, viscosifying agent HPMC-E 50 LV and antiglaucoma drug (betaxolol hydrochloride). Prepared in situ gels were evaluated for physical parameters like appearance, gelation temperature, pH, drug content, rheological properties, isotonicity, sterility test, in vitro permeation and in-vivo ocular irritation study. The drug released from selected batch provides sustained release of betaxolol over 7 hours period and showed excellent ocular tolerance. The overall results of this study supports that the Pluronic/HPMC based vehicle could be used for controlled drug release that exhibits a greater potential for glaucoma therapy.
A. Geethalakshmi, RoopaKarki, Poornima Sagi, Sajal Kumar Jha, Venkatesh.D.P., Temperature Triggered In situ Gelling System for Betaxolol in Glaucoma. J App Pharm Sci. 2013; 3 (02): 153-159.
533 Absract views 8 PDF Downloads 541 Total views
Clinical effectiveness and safety of brimonidine (0.2%) versus Dorzolamide (2.0%) in primary open angleSharma Neetu, Gupta Anita, Singh Gursatinder
pH-induced in situ gelling system of an anti-infective drug for sustained ocular delivery
Fabrication and Evaluation of Ketorolac Loaded Cubosome for Ocular Drug Delivery
Nanocarriers for Alzheimer’s disease: Research and patent updateKamla Pathak, Shashi Kiran Mishra, Amit Porwal, Shiv Bahadur